# Corryn Biotechnologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/corryn-biotechnologies

- Industry: Medical Devices & Equipment
- Headquarters: UK
- Website: www.corryn.co.uk/
- Total disclosed funding: $0.2M
- Latest round: Seed (Jul 24, 2024)
- Investors on record: 1

## About

Founded in 2021 and based in Wales, UK, Corryn Biotechnologies Ltd develops a wound dressing device with applicators that employ voltages to extrude fine fibers from fluids. In September 2024, the firm raised GBP 550,000 in Seed funding from the investor British Design Fund. The round was part of a larger GBP 550,000 Seed funding round. The company was co-founded by Dr. Luke Burke and Dr. Fabio Zomer Volpato.

The company offers biomimetic nano- and micro-fibrous wound dressing solutions. These dressings are designed to be fabricated and deposited directly onto wound sites at the point of care. The firm technology enables the creation of wound dressings from various material platforms, both with and without beneficial additives that promote wound healing. Central to this technology is an in-house developed handheld applicator device. This device is equipped with sealed sterile cartridges containing proprietary material formulations. Using a process known as electrospinning, these formulations are converted into fibrous substrates and deposited onto the patient's wound.

The company plans to use the September 2024 funding to develop its cutting-edge wound dressing technology, intended to manage complicated and chronic wounds.

## Funding rounds

- Seed, Jul 24, 2024, $0.2M — British Design Fund

## Investors

- British Design Fund (https://capitalatlas.ai/funds/british-design-fund) — Seed